MMDr Marty Makary — no licensed photograph is available, so the academic plate is shown instead.

Academic

Dr Marty Makary

former Trump FDA commissioner

Press citations

4

Topics

3

Rare diseases

Last quoted

Sept 2026

Dr Marty Makary: key facts

Kind of voice
Academic
Role
former Trump FDA commissioner
Quoted on
Rare diseases, Women's health & gynaecology, Public health & prevention
Tracked press citations
4
Most recently quoted
30 Sept 2026
First quoted
10 Sept 2026

“Commissioner Marty Makary, M.D., touted regulatory flexibility for orphan drugs.”

What Dr Marty Makary has said

Where Dr Marty Makary has been quoted

  1. FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?fiercepharma.com · 30 Sept 2026
  2. ‘Black box’ safety warning to be removed from hormone therapy for menopausecnn.com · 30 Sept 2026
  3. FDA Requests Removal of Boxed Warnings for Menopausal Hormone Therapyrheumatologyadvisor.com · 30 Sept 2026
  4. RFK Jr’s advisory panel overhaul stalled update on helping kids quit tobaccotheguardian.com · 10 Sept 2026

Related media coverage

Recent UK press coverage of their topics — not necessarily citing them directly.

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.